$PVCT running on this Provectus BioPharmaceutic
Post# of 22757
running on this
Provectus BioPharmaceuticals Inc. (PVCT) On June 22, 2015, we completed an investment in Provectus BioPharmaceuticals Inc., an NYSE listed company, that is a development-stage biopharmaceutical company primarily engaged in developing ethical pharmaceuticals for oncology and dermatology indications. The company's goal is to develop alternative treatments that are safer, more effective, less invasive and more economical than conventional therapies.